Abstract:Introduction: Costimulation blockade targeting the CD28 pathway provides improved long-term renal allograft survival compared to calcineurin inhibitors but may be limited as CTLA-4-Ig (abatacept, belatacept) blocks both CD28 costimulation and CTLA-4 coinhibition. Directly targeting CD28 while leaving CTLA-4 intact may provide a mechanistic advantage. Fc-silent non-crosslinking CD28 antagonizing domain antibodies (dAb) are currently in clinical trials for renal transplantation. Given the current standard of care in renal transplantation at most US centers, it is likely that lymphodepletion via thymoglobulin induction therapy could be used in patients treated with CD28 antagonists. Thus, we investigated the impact of T cell depletion (TCD) on T cell phenotype following homeostatic reconstitution in a murine model of skin transplantation treated with anti-CD28dAb. Methods: Skin from BALB/cJ donors was grafted onto C56BL/6 recipients which were treated with or without 0.2mg anti-CD4 and 10μg anti-CD8 one day prior to transplant and with or without 100μg anti-CD28dAb on days 0, 2, 4, 6, and weekly thereafter. Mice were euthanized six weeks post-transplant and lymphoid cells were analyzed by flow cytometry. Results: Anti-CD28dAb reversed lymphopenia-induced differentiation of memory CD4+ T cells in the spleen and lymph node compared to TCD alone. Mice treated with TCD+anti-CD28dAb exhibited significantly improved skin graft survival compared to anti-CD28dAb alone, which was also improved compared to no treatment. In addition, the expression of CD69 was reduced on CD4+ and CD8+ T cells in the spleen and lymph node from mice that received TCD+anti-CD28dAb compared to TCD alone. While a reduced frequency of CD4+FoxP3+ T cells was observed in anti-CD28dAb treated mice relative to untreated controls, this was balanced by an increased frequency of CD8+Foxp3+ T cells that was observed in the blood and kidney of mice given TCD+anti-CD28dAb compared to TCD alone. Discussion: These data demonstrate that CD28 signaling impacts the differentiation of both CD4+ and CD8+ T cells during homeostatic reconstitution following lymphodepletion, resulting in a shift towards fewer activated memory T cells and more CD8+FoxP3+ T cells, a profile that may underpin the observed prolongation in allograft survival.

[Effect of CD28 Costimulator on T Cell Receptor(tcr)-Induced Apoptosis of Thymocytes].

CD28 Signal Enhances Apoptosis of CD8 T Cells after Strong TCR Ligation

T Cell Costimulation Through Cd28 Depends on Induction of the Bcl-X Gamma Isoform: Analysis of Bcl-X Gamma-Deficient Mice

T Cell Costimulation through CD28 Depends on Induction of the Bcl-xγ Isoform

Study on the Signal Transduction in Apoptosis of L929 Cell Induced by IFNγ-LTα and LTα

Enhancement of sub-optimal doses of Con A-mediated activation and apoptosis of thymocytes by immobilized PF18-3 McAb

CD28 engagement inhibits CD73-mediated regulatory activity of CD8+ T cells

Susceptibility of Different Subsets of Immature Thymocytes to Apoptosis Induced by Anti-Tcrmab

CD28 Costimulation: From Mechanism to Therapy

Quantitative interplay between activating and pro-apoptotic signals dictates T cell responses

In vitro enhancing effects of thymic dendritic cells on apoptotic cell death of thymocytes

Selective CD28 blockade impacts T cell differentiation during homeostatic reconstitution following lymphodepletion

Early Apoptotic T Lymphocytes Induce DCs from Bone Marrow to Tolerogenic DCs

CD28 Shapes T Cell Receptor Signaling by Regulating ZAP70 Activation and Lck Dynamics

Influence of Sex Difference on the Apoptosis of Mouse Thymocytes Induced by Anti-TCR Antibodies

Co-receptor (CD4/CD8) engagement enhances CD3-induced apoptosis in thymocytes. Implications for negative selection.

The different effects of two thymic stromal cells on programmed cell death of thymocytes cultured in vitro

CD28-Specific Antibody Prevents Graft-Versus-Host Disease in Mice

Non-Fc Receptor-Binding Humanized Anti-CD3 Antibodies Induce Apoptosis of Activated Human T Cells

Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway

[CD28 costimulation and checkpoint inhibition in T cells]